Molecule Details
InChIKeyYQNWZWMKLDQSAC-UHFFFAOYSA-N
Compound NameVortioxetine
Canonical SMILESCc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)15
Pfam Stratification Cross-Family
Avg pChEMBL7.34
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB09068
Drug NameVortioxetine
CAS Number508233-74-7
Groups approved investigational
ATC Codes N06AX26
DescriptionVortioxetine is an antidepressant medication indicated for the treatment of major depressive disorder (MDD). It is classified as a serotonin modulator and stimulator (SMS) as it has a multimodal mechanism of action towards the serotonin neurotransmitter system whereby it simultaneously modulates one...

Categories: Agents that produce hypertension Anti-Anxiety Agents Antidepressive Agents Antidepressive Agents Indicated for Depression Central Nervous System Agents Central Nervous System Depressants Cytochrome P-450 CYP2A6 Substrates Cytochrome P-450 CYP2B6 Substrates Cytochrome P-450 CYP2C19 Substrates Cytochrome P-450 CYP2C8 Substrates Cytochrome P-450 CYP2C9 Substrates Cytochrome P-450 CYP2D6 Substrates Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A5 Substrates Cytochrome P-450 Substrates Drugs that are Mainly Renally Excreted Membrane Transport Modulators Nervous System Neurotransmitter Agents Neurotransmitter Uptake Inhibitors Piperazines Psychoanaleptics Psychotropic Drugs Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome Serotonin 5-HT1 Receptor Agonists Serotonin 5-HT1 Receptor Antagonists Serotonin 5-HT3 Receptor Antagonists Serotonin Agents Serotonin Modulators Serotonin Receptor Agonists Serotonin Receptor Antagonists Tranquilizing Agents
Cross-references: BindingDB: 50400902 ChEBI: 76016 CHEMBL2104993 ChemSpider: 8141643 Drugs Product Database (DPD): 22527 D10184 PDB: VTX PharmGKB: PA166122595 PubChem:71768094 PubChem:310265001 RxCUI: 1455099 Wikipedia: Vortioxetine ZINC: ZINC000034051848
Target Activities (15)
Target Gene Organism Category Pfam pChEMBL Type Source
P31645 SLC6A4 Homo sapiens Human PF03491 PF00209 8.5 IC50 ChEMBL;BindingDB
P35354 PTGS2 Homo sapiens Human PF03098 8.5 IC50 ChEMBL;BindingDB
P23219 PTGS1 Homo sapiens Human PF03098 8.3 IC50 ChEMBL;BindingDB
P08908 HTR1A Homo sapiens Human PF00001 8.0 Ki ChEMBL;BindingDB
P46098 HTR3A Homo sapiens Human PF02931 PF02932 7.9 Ki ChEMBL;BindingDB
P34969 HTR7 Homo sapiens Human PF00001 7.6 Ki ChEMBL;BindingDB
P28222 HTR1B Homo sapiens Human PF00001 7.5 Ki ChEMBL;BindingDB
P08588 ADRB1 Homo sapiens Human PF00001 7.3 Ki ChEMBL;BindingDB
P25021 HRH2 Homo sapiens Human PF00001 6.7 Ki ChEMBL;BindingDB
P28223 HTR2A Homo sapiens Human PF00001 6.7 Ki ChEMBL;BindingDB
P28335 HTR2C Homo sapiens Human PF00001 6.7 Ki ChEMBL;BindingDB
P35367 HRH1 Homo sapiens Human PF00001 6.7 Ki ChEMBL;BindingDB
P47898 HTR5A Homo sapiens Human PF00001 6.7 Ki ChEMBL;BindingDB
P50406 HTR6 Homo sapiens Human PF00001 6.5 Ki ChEMBL;BindingDB
P07550 ADRB2 Homo sapiens Human PF00001 6.2 Ki ChEMBL;BindingDB
DrugBank Target Actions (15)
Target Gene Target Name Action Type
P08684 CYP3A4 Cytochrome P450 3A4 substrate enzymes
P10632 CYP2C8 Cytochrome P450 2C8 substrate enzymes
P10635 CYP2D6 Cytochrome P450 2D6 substrate enzymes
P11509 CYP2A6 Cytochrome P450 2A6 substrate enzymes
P11712 CYP2C9 Cytochrome P450 2C9 substrate enzymes
P20813 CYP2B6 Cytochrome P450 2B6 substrate enzymes
P20815 CYP3A5 Cytochrome P450 3A5 substrate enzymes
P33261 CYP2C19 Cytochrome P450 2C19 substrate enzymes
P08908 HTR1A 5-hydroxytryptamine receptor 1A agonist targets
P34969 HTR7 5-hydroxytryptamine receptor 7 antagonist targets
P46098 HTR3A 5-hydroxytryptamine receptor 3A antagonist targets
P23975 SLC6A2 Sodium-dependent noradrenaline transporter blocker targets
P31645 SLC6A4 Sodium-dependent serotonin transporter inhibitor targets
P08588 ADRB1 Beta-1 adrenergic receptor ligand targets
P28222 HTR1B 5-hydroxytryptamine receptor 1B partial agonist targets